Hikma Pharmaceuticals PLC
(LSE:HIK)
£
19.58
-0.36 (-1.81%)
Market Cap: 4.34 Bil
Enterprise Value: 5.10 Bil
PE Ratio: 29.14
PB Ratio: 2.49
GF Score: 93/100 - Full Year 2023 Hikma Pharmaceuticals PLC Earnings Call TranscriptFeb 22, 2024£20.83 (+4.28%)Earnings
- Full Year 2023 Hikma Pharmaceuticals PLC Earnings Presentation (Pre-Recorded) TranscriptFeb 22, 2024
- Hikma Pharmaceuticals PLC at JPMorgan Healthcare Conference TranscriptJan 10, 2024
- Half Year 2023 Hikma Pharmaceuticals PLC Earnings Call TranscriptAug 03, 2023£20.6 (-0.72%)Earnings
- Half Year 2023 Hikma Pharmaceuticals PLC Earnings Presentation - Pre-Recorded TranscriptAug 03, 2023
- Full Year 2022 Hikma Pharmaceuticals PLC Earnings Call TranscriptFeb 23, 2023£17.18 (-2.02%)Earnings
- Full Year 2022 Hikma Pharmaceuticals PLC Earnings Presentation - Pre-Recorded TranscriptFeb 23, 2023
- Hikma Pharmaceuticals PLC at JPMorgan Healthcare Conference TranscriptJan 11, 2023
- Half Year 2022 Hikma Pharmaceuticals PLC Earnings Call TranscriptAug 04, 2022£16.51 (-6.33%)Earnings
- Half Year 2022 Hikma Pharmaceuticals PLC Earnings Pre-Recorded Presentation TranscriptAug 04, 2022
- Full Year 2021 Hikma Pharmaceuticals PLC Earnings Call - Q&A Session TranscriptFeb 24, 2022£18.34 (-8.92%)Earnings
- Full Year 2021 Hikma Pharmaceuticals PLC Earnings Presentation - Pre-Recorded TranscriptFeb 24, 2022
- Hikma Pharmaceuticals PLC at JPMorgan Healthcare Conference (Virtual) TranscriptJan 12, 2022
- Half Year 2021 Hikma Pharmaceuticals PLC Earnings Call (Q&A Session) TranscriptAug 06, 2021£24.55 (-7.08%)Earnings
- Half Year 2021 Hikma Pharmaceuticals PLC Earnings Presentation - Pre-Recorded TranscriptAug 06, 2021
- Hikma Pharmaceuticals PLC Meet the Management Event: Branded TranscriptJun 22, 2021
- Hikma Pharmaceuticals PLC Annual Shareholders Meeting TranscriptApr 23, 2021
- Hikma Pharmaceuticals PLC Meet the Management Event: Injectables TranscriptMar 24, 2021
- Full Year 2020 Hikma Pharmaceuticals PLC Earnings Call (Q&A Session) TranscriptFeb 25, 2021£23.39 (-3.23%)Earnings
- Full Year 2020 Hikma Pharmaceuticals PLC Pre-Recorded Earnings Presentation TranscriptFeb 25, 2021
- Hikma Pharmaceuticals PLC at JPMorgan Healthcare Conference (Virtual) TranscriptJan 12, 2021
- Half Year 2020 Hikma Pharmaceuticals PLC Earnings Call (Q&A Session) TranscriptAug 07, 2020£23.93 (+10.94%)Earnings
- Half Year 2020 Hikma Pharmaceuticals PLC Pre-Recorded Earnings Presentation TranscriptAug 07, 2020
- Full Year 2019 Hikma Pharmaceuticals PLC Earnings Call TranscriptFeb 27, 2020£19.1 (+4.63%)Earnings
- Half Year 2019 Hikma Pharmaceuticals PLC Earnings Call TranscriptAug 09, 2019£19.54 (+6.11%)Earnings
- Full Year 2018 Hikma Pharmaceuticals PLC Earnings Call TranscriptMar 13, 2019£15.85 (-4.29%)Earnings
Half Year 2020 Hikma Pharmaceuticals PLC Pre-Recorded Earnings Presentation Transcript
Aug 07, 2020 / 07:00AM GMT
Release Date Price:
£23.93
(+10.94%)
Sigurdur Oli Olafsson
Hikma Pharmaceuticals PLC - CEO & Executive Director
Presentation
Aug 07, 2020 / 07:00AM GMT
=====================
Corporate Participants
=====================
* Khalid Waleed Hosny Al Nabilsi
Hikma Pharmaceuticals PLC - CFO
* Sigurdur Oli Olafsson
Hikma Pharmaceuticals PLC - CEO & Executive Director
=====================
-
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent ![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust_rating.png)
4.6 out of 5
Trustpilot
![](https://static.gurufocus.com/trust.png)